Concepedia

Publication | Open Access

Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults

62

Citations

28

References

2021

Year

Abstract

GlaxoSmithKline Biologicals SA, Bill and Melinda Gates Foundation.

References

YearCitations

Page 1